While CLIC1 activity itself may not be a determinant in the development of GBM (Barbieri et al., 2022), its suppression appears to influence the characteristics of glioma stem cells and their response to novel biguanide derivatives (Peretti et al., 2018). This evidence concerns the gene CLIC1 and central nervous system cancer.